IP Library Granted Patent US 11,147,836
Granted Patent B2
US 11,147,836 · App. 16/726,099 · Granted Oct 19, 2021

Method for producing an osteoinductive calcium phosphate and products thus obtained

Inventors: Florence De Groot-Barrere (Bilthoven, NL); Vincent Van Miegem (Bilthoven, NL); Huipin Yuan (Bilthoven, NL); Joost De Bruijn (Bilthoven, NL)
Assignee: KUROS BIOSCIENCES B.V.
A61K33/42A61K9/14A61L27/12A61L27/32A61L27/50A61L27/56A61L2400/12A61L2400/18A61L2430/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,147,836
App. No.
16/726,099
Granted
Oct 19, 2021
Kind
B2
Abstract

The invention relates to a method for producing an osteoinductive calcium phosphate material, the method comprising the steps of providing a sintered calcium phosphate starting material having a surface topography consisting of calcium phosphate grains, subjecting the sintered calcium phosphate starting material to a hydrothermal treatment of between 125-150° C. for a duration sufficient to change calcium phosphate grains on the surface of the starting material into calcium phosphate needles.

Claims (17)

1. A method to induce formation of bone tissue in a subject, which method comprises providing said subject with an osteoinductive material which comprises an outer layer comprising hydroxyapatite needles and an inner layer that is in contact with the outer layer, wherein the inner layer comprises a sintered biphasic calcium phosphate (BCP) of beta-tricalcium phosphate and hydroxyapatite, wherein the sintered BCP comprises 4-20 wt. % of hydroxyapatite; whereby the outer layer is a precipitate of hydroxyapatite needles from the sintered BCP of the inner layer following the hydrothermal treatment thereof at a temperature equal to or higher than 125° C.

2. The method of claim 1 , wherein the providing is in the context of dental surgery.

3. The method of claim 1 , wherein the providing is in the context of maxillofacial or orthopedic surgery, or musculoskeletal surgery in bone repair.

4. The method of claim 1 , wherein the material is provided as an implant or tissue scaffold.

5. The method of claim 4 , wherein the implant or scaffold is placed in a non-osseous site.

6. The method of claim 5 , wherein the implant or scaffold is provided along with one or more growth factors or cells.

7. The method of claim 1 , wherein the material is provided as an injectable.

8. The method of claim 1 , wherein the osteoinductive material is provided in combination with a medical implant of a different material on which the osteoinductive material is present in the form of a coating.

9. The method of claim 1 , wherein the different material is a metal or a polymeric material.

10. The method of claim 1 , wherein the sintered BCP has a surface topography consisting of calcium phosphate grains.

11. The method of claim 1 , wherein the sintered BCP has an average grain size in a range of 0.1-3.0 μm.

12. The method of claim 1 , wherein the sintered BCP is porous.

13. The method of claim 1 , wherein the sintered BCP comprises macropores in a size range of 50-1500 μm.

14. The method of claim 1 , wherein the needles have a diameter of 10-1500 nm.

15. The method of claim 1 , wherein the BCP is resorbable.

16. The method of claim 1 , wherein the outer layer has a BET specific surface area above 0.9 m2/g.

17. The method of claim 1 , wherein the density of needles in the outer layer is lower than 0.45/μm2.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 26, 2020
From: DE GROOT-BARRERE, FLORENCE; VAN MIEGEM, VINCENT; YUAN, HUIPIN; DE BRUIJN, JOOST
To: XPAND BIOTECHNOLOGY B.V.
Reel/Frame 052753/0151 →
CHANGE OF NAME Recorded May 26, 2020
From: XPAND BIOTECHNOLOGY B.V.
To: KUROS BIOSCIENCES B.V.
Reel/Frame 052755/0239 →
Priority Claims (1)
NL 2011195 · Jul 18, 2013 · national
Continuity (3)
Division 16045961 · Jul 26, 2018
Division 14904676
Related Publication 20200129548A1 · Apr 30, 2020